These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1312296)

  • 1. Angiotensin-converting enzyme in renal and cerebral tissue and implications for successful blood pressure management.
    Reams GP
    Am J Cardiol; 1992 Apr; 69(10):59C-64C. PubMed ID: 1312296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme in cardiovascular and adrenal tissues and implications for successful blood pressure management.
    Melby JC
    Am J Cardiol; 1992 Apr; 69(10):2C-7C. PubMed ID: 1546636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control.
    Johnston CI
    J Hypertens Suppl; 1992 Dec; 10(7):S13-26. PubMed ID: 1337911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue angiotensin converting enzyme inhibition. Relevant to clinical practice?
    Lees KR; MacFadyen RJ; Reid JL
    Am J Hypertens; 1990 Nov; 3(11):266S-272S. PubMed ID: 2175623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases.
    Lazartigues E; Feng Y; Lavoie JL
    Curr Pharm Des; 2007; 13(12):1231-45. PubMed ID: 17504232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma renin activity and changes in tissue angiotensin converting enzyme.
    Michel B; Grima M; Stephan D; Coquard C; Welsch C; Barthelmebs M; Imbs JL
    J Hypertens; 1994 May; 12(5):577-84. PubMed ID: 7930558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    Unger T; Gohlke P
    Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems.
    Lee MA; Paul M; Böhm M; Ganten D
    Am J Cardiol; 1992 Oct; 70(10):12C-19C. PubMed ID: 1414888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibition: prospects for the future.
    Jackson B; Mendelsohn FA; Johnston CI
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S4-8. PubMed ID: 1725200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitors and moderate hypertension.
    McAreavey D; Robertson JI
    Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors.
    Johnston CI; Mendelsohn FA; Cubela RB; Jackson B; Kohzuki M; Fabris B
    J Hypertens Suppl; 1988 Dec; 6(3):S17-22. PubMed ID: 2852234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating versus local renin-angiotensin system in cardiovascular homeostasis.
    Dzau VJ
    Circulation; 1988 Jun; 77(6 Pt 2):I4-13. PubMed ID: 3286045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?
    Sambhi MP; Gavras H; Robertson JI; Smith WM
    West J Med; 1993 Mar; 158(3):286-94. PubMed ID: 8460511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue renin-angiotensin systems and their modulation: the heart as a paradigm for new aspects of converting enzyme inhibition.
    Lindpaintner K; Ganten D
    Cardiology; 1991; 79 Suppl 1():32-44. PubMed ID: 1655263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses.
    Davis JL; Kruger K; LaFevers DH; Barlow BM; Schirmer JM; Breuhaus BA
    Equine Vet J; 2014 Nov; 46(6):729-33. PubMed ID: 24175935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA; Derkx FH; van den Meiracker AH
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renin-angiotensin system as a target for therapeutic intervention.
    Swales JD
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-5. PubMed ID: 7898088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New angiotensin converting enzyme inhibitors. Their role in the management of hypertension.
    Laragh JH
    Am J Hypertens; 1990 Nov; 3(11):257S-265S. PubMed ID: 2261144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.